| UBS (LUX) EQUITY SICAV - USA GROWTH (USD) I-A1-ACC | RVI USA CRECIMIENTO | 17,29% | 78,94% | 77,88% | 367,81% |
| JPM JAPAN STRATEGIC VALUE A (ACC) EUR (HEDGED) | RVI JAPÓN VALOR | 46,51% | 135,99% | 202,25% | 367,50% |
| BNP PARIBAS US GROWTH I CAP | RVI USA CRECIMIENTO | 27,37% | 82,17% | 81,32% | 366,93% |
| PRIVILEDGE - ALPHA JAPAN (EUR) N CAP SYST. HDG | RVI JAPÓN | 32,64% | 109,68% | 151,52% | 366,38% |
| INVESCO STOXX EUROPE 600 OPTIMISED BANKS UCITS ETF ACC | RVI FINANCIERO | 44,19% | 217,65% | 291,55% | 362,33% |
| NOMURA FUNDS IRELAND - JAPAN STRATEGIC VALUE FUND ID USD HEDGED | RVI JAPÓN VALOR | 33,93% | 103,40% | 202,52% | 362,18% |
| BANKINTER EE.UU. NASDAQ 100, FI R | RVI TECNOLOGÍA | 21,42% | 80,75% | 67,88% | 361,58% |
| BNP PARIBAS US GROWTH PRIVILEGE CAP | RVI USA CRECIMIENTO | 27,24% | 81,61% | 80,34% | 360,88% |
| POLAR CAPITAL BIOTECHNOLOGY R USD DIS | RVI BIOTECNOLOGÍA | 60,61% | 104,35% | 101,36% | 360,84% |
| POLAR CAPITAL BIOTECHNOLOGY R GBP DIS | RVI BIOTECNOLOGÍA | 60,47% | 103,78% | 101,50% | 360,35% |
